Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer.

Luca Bertolaccini, Francesco Ricchetti, Filippo Alongi, Alberto Terzi, Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future? Annals of Translational Medicine. ,vol. 3, pp. 25- 25 ,(2015) , 10.3978/J.ISSN.2305-5839.2015.01.06

A Szpechcinski, J Chorostowska-Wynimko, R Struniawski, W Kupis, P Rudzinski, R Langfort, E Puscinska, P Bielen, P Sliwinski, T Orlowski, Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease. British Journal of Cancer. ,vol. 113, pp. 476- 483 ,(2015) , 10.1038/BJC.2015.225

Ellen Heitzer, Martina Auer, Eva Maria Hoffmann, Martin Pichler, Christin Gasch, Peter Ulz, Sigurd Lax, Julie Waldispuehl‐Geigl, Oliver Mauermann, Sumitra Mohan, Gunda Pristauz, Carolin Lackner, Gerald Höfler, Florian Eisner, Edgar Petru, Heinz Sill, Hellmut Samonigg, Klaus Pantel, Sabine Riethdorf, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher, Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancer International Journal of Cancer. ,vol. 133, pp. 346- 356 ,(2013) , 10.1002/IJC.28030

James B. Yu, Pamela R. Soulos, Laura D. Cramer, Roy H. Decker, Anthony W. Kim, Cary P. Gross, Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer. ,vol. 121, pp. 2341- 2349 ,(2015) , 10.1002/CNCR.29359

Julie Earl, Sandra Garcia-Nieto, Jose Carlos Martinez-Avila, José Montans, Alfonso Sanjuanbenito, Mercedes Rodríguez-Garrote, Eduardo Lisa, Elena Mendía, Eduardo Lobo, Núria Malats, Alfredo Carrato, Carmen Guillen-Ponce, Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer. BMC Cancer. ,vol. 15, pp. 797- 797 ,(2015) , 10.1186/S12885-015-1779-7

Heidi Schwarzenbach, Dave S. B. Hoon, Klaus Pantel, Cell-free nucleic acids as biomarkers in cancer patients Nature Reviews Cancer. ,vol. 11, pp. 426- 437 ,(2011) , 10.1038/NRC3066

Sukki Cho, Sook-Whan Sung, Sanghoon Jheon, Jin-Haeng Chung, Risk of recurrence in surgically resected stage I adenocarcinoma of the lung: histopathologic and immunohistochemical analysis. Lung. ,vol. 186, pp. 411- 419 ,(2008) , 10.1007/S00408-008-9116-4

Chanida Vinayanuwattikun, Pakorn Winayanuwattikun, Poonchavist Chantranuwat, Apiwat Mutirangura, Virote Sriuranpong, The impact of non-tumor-derived circulating nucleic acids implicates the prognosis of non-small cell lung cancer Journal of Cancer Research and Clinical Oncology. ,vol. 139, pp. 67- 76 ,(2013) , 10.1007/S00432-012-1300-5

Akshata Ramrao Udyavar, Megan Hoeksema, Kirsten Diggins, Jonathan Irish, Pierre P Massion, Vito Quaranta, None, Abstract B27: Phenotypic plasticity and heterogeneity in small cell lung cancer (SCLC): Novel molecular subtypes and potential for targeted therapy. Clinical Cancer Research. ,vol. 20, ,(2014) , 10.1158/1078-0432.14AACRIASLC-B27

Jean-Yves Douillard, Gyula Ostoros, Manuel Cobo, Tudor Ciuleanu, Rebecca Cole, Gael McWalter, Jill Walker, Simon Dearden, Alan Webster, Tsveta Milenkova, Rose McCormack, Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status Journal of Thoracic Oncology. ,vol. 9, pp. 1345- 1353 ,(2014) , 10.1097/JTO.0000000000000263